In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Jeremy Zhang, Senior Director and Head of Data Science Solutions at Otsuka, to discuss why AI initiatives succeed or fail in pharma and why it has almost nothing to do with the technology itself.

Jeremy Zhang is the Senior Director and Head of Data Science Solutions at Otsuka, where  he leads enterprise-wide AI and advanced analytics initiatives across R&D, clinical development, and corporate functions, helping translate complex data science into practical, decision-driving value. With prior experience at Gilead Sciences scaling AI for clinical trial optimization and real-world data integration, Jeremy brings a grounded, pragmatic perspective on what it really takes to move AI from hype to impact in pharma.

Episode Highlights:

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com